First, we validated TLR7/8 expression in the mouse and human glioma TME using a recently published single-cell RNA sequencing dataset of infiltrating CD45+ immune cells in treatment-naive murine syngeneic Gl261 tumors and human glioma10. The gene discussed is TLR7; the disease is central nervous system cancer.